Part Details | ESTRADIOL TRANSDERMAL SYSTEM
6505-01-533-5293
Alternate Parts: 051552, 05-1552, VIVELLEDOT, VIVELLE-DOT, NDC00078034545, NDC00078-0345-45, 6505-01-533-5293, 01-533-5293, 6505015335293, 015335293
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | SEP 19, 2005 | 01-533-5293 | 38827 ( ESTRADIOL TRANSDERMAL SYSTEM ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-533-5293
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 05-1552 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| VIVELLE-DOT | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
| NDC00078-0345-45 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
Technical Data | NSN 6505-01-533-5293
| Characteristic | Specifications |
|---|---|
| USUAL DOSE | 0.075MG RELEASE PER 24 HOURS |
| OVERALL STRENGTH IN SYSTEM | 1.17MG ESTRADIOL USP ACTIVE INGREDIENT |
| SYSTEM SIZE | 7.5 SQUARE CENTIMETERS |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| SPECIAL FEATURES | USED IN THE TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE AND PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS; 8 INDIVIDUAL SEALED PATCHES PER BOX, 3 BOXES PER PKG (TOTAL OF 24 PATCHES); DO NOT STORE UNPOUCHED, APPLY IMMEDIATELY UPON REMOVAL FROM THE PROTECTIVE POUCH; STORE AT CONTROLLED ROOM TEMPERATURE 25DEG C |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ESTRADIOL TRANSDERMAL SYSTEM 0.075MG/24 HOURS PATCH 8EA 3S |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 681604 |